A new report by UNICEF and UNAIDS has raised concern over a significant decline in the use of HIV prevention medication in Nigeria, warning that the drop could reverse years of progress in the fight against the virus.
The document, titled “Their Future Is on the Line: Cost of Inaction on HIV for Children,” shows that access to pre-exposure prophylaxis (PrEP)—a drug taken by people at high risk of HIV—has fallen sharply in Nigeria, Togo and Uganda. The decline is linked to reduced funding and disruptions in supply chains across many African countries.
According to the UN agencies, nearly one in four of the 56 countries surveyed reported having less than six months of condoms or PrEP in stock, while almost half are struggling with supply chain issues. They warned that these shortages put women, adolescents and other at-risk groups at greater risk of infection.
The study noted that prevention programmes previously helped cut HIV infections among young women and adolescent girls by half since 2010. But many of these initiatives have lost major financial support, limiting access to prevention tools and testing services.
The report also highlighted regional inequalities. Eastern and southern Africa have seen strong treatment coverage for pregnant women living with HIV, reaching up to 93 per cent. In contrast, western and central Africa—where Nigeria belongs—recorded coverage of only about 56 per cent.
The UN analysis stressed that fewer pregnant women are being diagnosed or starting treatment early, not because infection rates have dropped, but because services are harder to reach. It warned that if funding continues to fall, the world could record an additional 1.1 million HIV infections and 820,000 deaths by 2040, with children in sub-Saharan Africa most affected.
Despite the challenges, the report acknowledged that some countries are taking steps to protect progress. Nigeria, for instance, approved $3.12 million for HIV treatment and is working on an AIDS Trust Fund to support long-term financing. The health sector has also adjusted drug quantities, mobilised state resources and harmonised supply chains for HIV, malaria and tuberculosis medicines.
The UN agencies called for urgent, sustained investment to prevent further setbacks, stressing that global efforts have already saved millions of lives. They warned that without renewed commitment, children, mothers and communities could face devastating consequences.
The report concludes that the world must act now to prevent funding gaps from widening, saying the future of millions of children depends on consistent access to prevention and treatment services.